AstraZeneca’s chronic obstructive pulmonary disease drug candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded...
Senior HHS official and head of Medicare Chris Klomp didn’t mince words when he called competition with China’s ascending biotech industry “a war.” Klomp’s comments, made...
Novartis has penned a $2 billion deal for a biotech whose next-gen anti-IgE program could offer a worthy successor to Xolair.
Scientists have developed a breakthrough “superfood” for honeybees by engineering yeast to produce the essential nutrients normally found in pollen. In controlled trials, colonies fed this...
The Food and Drug Administration approved on Thursday a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable...
Nature Biotechnology, Published online: 27 March 2026; doi:10.1038/s41587-026-03074-8 Unpaired data as a first-order challenge in single-cell and spatial proteomics
Nature Biotechnology, Published online: 27 March 2026; doi:10.1038/s41587-026-03046-y Variant mapping of sorghum promoters identifies CRISPR-accessible mutations that upregulate gene expression.
Nature Biotechnology, Published online: 27 March 2026; doi:10.1038/s41587-026-03053-z A long-read metagenome assembly method recovers circular and complete genomes better than existing tools.
Nature Biotechnology, Published online: 27 March 2026; doi:10.1038/s41587-026-03044-0 New capabilities for controlling drug delivery into cells are developed using DNA–drug conjugates.
Neion Bio has emerged from stealth mode and signed its first co-development and supply agreement with an unnamed major global pharmaceutical company. Neion’s Raptor platform products...